179 related articles for article (PubMed ID: 12550754)
21. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3.
Jha P; Jha P; Pathak P; Chosdol K; Suri V; Sharma MC; Kumar G; Singh M; Mahapatra AK; Sarkar C
Exp Mol Pathol; 2011 Apr; 90(2):167-72. PubMed ID: 21115003
[TBL] [Abstract][Full Text] [Related]
22. p53 Codon 72 polymorphism and the risk of esophageal squamous cell carcinoma.
Yang W; Zhang Y; Tian X; Ning T; Ke Y
Mol Carcinog; 2008 Feb; 47(2):100-4. PubMed ID: 17918207
[TBL] [Abstract][Full Text] [Related]
23. Multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene?
Gallo O; Sardi I; Pepe G; Franchi A; Attanasio M; Giusti B; Bocciolini C; Abbate R
Int J Cancer; 1999 Jul; 82(2):180-6. PubMed ID: 10389749
[TBL] [Abstract][Full Text] [Related]
24. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.
Hernandez L; Fest T; Cazorla M; Teruya-Feldstein J; Bosch F; Peinado MA; Piris MA; Montserrat E; Cardesa A; Jaffe ES; Campo E; Raffeld M
Blood; 1996 Apr; 87(8):3351-9. PubMed ID: 8605352
[TBL] [Abstract][Full Text] [Related]
25. Mutation in the p53 tumor suppressor gene in rat esophageal papillomas induced by N-nitrosomethylbenzylamine.
Wang D; Weghorst CM; Calvert RJ; Stoner GD
Carcinogenesis; 1996 Apr; 17(4):625-30. PubMed ID: 8625469
[TBL] [Abstract][Full Text] [Related]
26. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
[TBL] [Abstract][Full Text] [Related]
27. p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy.
Rugge M; Bovo D; Busatto G; Parenti AR; Fawzy S; Guido M; Ancona E; Ninfo V; Ruol A; Shiao YH
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):171-6. PubMed ID: 9138659
[TBL] [Abstract][Full Text] [Related]
28. Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells.
Clark LS; Hart DW; Vojta PJ; Harrington-Brock K; Barrett JC; Moore MM; Tindall KR
Mutagenesis; 1998 Sep; 13(5):427-34. PubMed ID: 9800187
[TBL] [Abstract][Full Text] [Related]
29. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.
Chang F; Syrjänen S; Tervahauta A; Kurvinen K; Wang L; Syrjänen K
Br J Cancer; 1994 Aug; 70(2):346-51. PubMed ID: 8054284
[TBL] [Abstract][Full Text] [Related]
30. TP53 mutations in upper aerodigestive squamous cell carcinomas from a group of Brazilian patients.
Nagai MA; Miracca EC; Yamamoto L; Kowalski LP; Brentani RR
Am J Surg; 1995 Nov; 170(5):492-4. PubMed ID: 7485740
[TBL] [Abstract][Full Text] [Related]
31. p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort.
Pantelis A; Pantelis D; Ruemmele P; Hartmann A; Hofstaedter F; Buettner R; Bootz F; Stoehr R
Oncol Rep; 2007 May; 17(5):1243-8. PubMed ID: 17390072
[TBL] [Abstract][Full Text] [Related]
32. Polymorphism and allelic loss at the AS3 locus on 13q12-13 in esophageal squamous cell carcinoma.
Harada H; Uchida N; Shimada Y; Kumimoto H; Shinoda M; Imamura M; Ishizaki K
Int J Oncol; 2001 May; 18(5):1003-7. PubMed ID: 11295048
[TBL] [Abstract][Full Text] [Related]
33. Analysis of TGF-beta type I receptor for mutations and polymorphisms in head and neck cancers.
Knobloch TJ; Lynch MA; Song H; DeGroff VL; Casto BC; Adams EM; Alam KY; Lang JC; Schuller DE; Weghorst CM
Mutat Res; 2001 Aug; 479(1-2):131-9. PubMed ID: 11470488
[TBL] [Abstract][Full Text] [Related]
34. [Correlation between mutation of p53 gene 2-4 exons from peripheral blood and HPV16 positive cervical cancer susceptibility and clinical significance].
Yin CM; Yao YF; Yan ZL; Yang HY
Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):320-326. PubMed ID: 28545270
[No Abstract] [Full Text] [Related]
35. TP53 mutations in primary breast carcinomas from white and African-Brazilian patients.
Nagai MA; Schaer Barbosa H; Zago MA; Araújo Silva W; Nishimoto IN; Salaorni S; Guerreiro Costa LN; Silva Araújo M; Caldas Oliveira AG; Mourâo Neto M; Brentani MM
Int J Oncol; 2003 Jul; 23(1):189-96. PubMed ID: 12792793
[TBL] [Abstract][Full Text] [Related]
36. A non-random deletion in the p53 gene in oral squamous cell carcinoma.
Nylander K; Schildt EB; Eriksson M; Magnusson A; Mehle C; Roos G
Br J Cancer; 1996 Jun; 73(11):1381-6. PubMed ID: 8645583
[TBL] [Abstract][Full Text] [Related]
37. p16 tumor suppressor gene mutations in Chinese esophageal carcinomas in Hong Kong.
Chan WC; Tang CM; Lau KW; Lung ML
Cancer Lett; 1997 May; 115(2):201-6. PubMed ID: 9149125
[TBL] [Abstract][Full Text] [Related]
38. p53 mutations in human papillomavirus-associated oesophageal squamous cell carcinoma.
Cooper K
Br J Cancer; 1995 Nov; 72(5):1337. PubMed ID: 7577493
[No Abstract] [Full Text] [Related]
39. TP53 gene status and human papilloma virus infection in response to platinum plus taxane-based chemotherapy of epithelial ovarian carcinomas.
Malisic E; Jankovic R; Jakovljevic K; Radulovic S
J BUON; 2011; 16(4):701-7. PubMed ID: 22331725
[TBL] [Abstract][Full Text] [Related]
40. Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia.
Thiart R; Scholtz CL; Vergotine J; Hoogendijk CF; de Villiers JN; Nissen H; Brusgaard K; Gaffney D; Hoffs MS; Vermaak WJ; Kotze MJ
J Med Genet; 2000 Jul; 37(7):514-9. PubMed ID: 10882754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
